Respiratory Clinical Trials was first established in 1999 (formerly known as Adelaide Respiratory Research then Respiratory Research Foundation) and has conducted more than 135 outpatient (phase II, III and IV) studies and inpatient studies in partnership with pharmaceutical companies. Due to our competitive ability we have previously recruited in other therapeutic areas which include an oral anti-coagulant for use post surgery, a one-dose Japanese encephalitis vaccine and observational studies including non-cancer, opioid-induced constipation.

As of June 2024, Respiratory Clinical Trials is currently conducting studies for common respiratory diseases including asthma and idiopathic pulmonary fibrosis (IPF) and are always looking to be involved in studies for other respiratory conditions. We have successfully recruited for and conducted trials for patients living with COPD, asthma, bronchiectasis, IPF, and many more during our long and successful history. Our site encourages individuals living with a range of diseases, not just those mentioned previously, to contact us if they wish to be involved.